RBC Capital raised the firm’s price target on Oxford Biomedica (OXBDF) to 970 GBp from 930 GBp and keeps an Outperform rating on the shares.
Claim 70% Off TipRanks Premium
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on OXBDF:
- Oxford Biomedica Reports Strong Revenue Growth in 2025
- Oxford BioMedica Reports Robust H1 2025 Results, Strengthens Market Position
- Oxford Biomedica Announces Total Voting Rights Update
- Oxford Biomedica price target raised to 930 GBp from 800 GBp at RBC Capital
- Oxford Biomedica Director’s Share Transaction Error and Resolution